series-a
Stage
2018
Founded
2
Investors
About
Trogenix Ltd is a clinical-stage oncology company developing precision cancer therapies using its proprietary Synthetic Super-Enhancer (SSE) technology, targeting aggressive solid tumors like glioblastoma with a potentially curative, one-time treatment approach.
Explore Trogenix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.